Cargando…
Relationship of concomitant anti-diabetic drug administration with sodium-glucose co-transporter 2 inhibitor-related ketosis
OBJECTIVE: The use of sodium-glucose co-transporter 2 inhibitors (SGLT2is) may be associated with ketoacidosis. Therefore, the associated risk factors should be identified. In particular, information regarding the effects of the co-administration of anti-diabetic drugs is lacking. METHODS: We perfor...
Autores principales: | Lin, Cheng-Wei, Hung, Shih-Yuan, Chen, I-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973047/ https://www.ncbi.nlm.nih.gov/pubmed/35352579 http://dx.doi.org/10.1177/03000605221090095 |
Ejemplares similares
-
Role of nutritional ketosis in the improvement of metabolic parameters following bariatric surgery
por: Pindozzi, Fioralba, et al.
Publicado: (2022) -
Sodium glucose transporter 2 inhibition, euglycemic ketosis and bone mineral loss: Refining clinical practices
por: Dutta, Deep, et al.
Publicado: (2015) -
Ketosis-Onset Diabetes and Ketosis-Prone Diabetes: Same or Not?
por: Liu, Beiyan, et al.
Publicado: (2013) -
Anti-Arrhythmic Effects of Sodium-Glucose Co-Transporter 2 Inhibitors
por: Jing, Yuling, et al.
Publicado: (2022) -
Blood glucose changes surrounding initiation of tumor-necrosis factor inhibitors and conventional disease-modifying anti-rheumatic drugs in veterans with rheumatoid arthritis
por: Wood, Patrick R, et al.
Publicado: (2018)